AC
Insider selling
Abraham Ceesay sold $64K of RAPP stock
Abraham Ceesay, Chief Executive Officer of Rapport Therapeutics, Inc. (RAPP), sold 2,210 shares of RAPP stock worth $64K, per an SEC Form 4 filed Oct 23, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 21, 2026, 2 days before it was made public.
RAPP has moved +3.5% since the trade date, from $25.06 to $25.93 (Oct 23, 2026 close).
- Traded
- Oct 21, 2026
- Disclosed
- Oct 23, 2026
- Filing delay
- 2 days
- Price since
- +3.5%
- Role
- Chief Executive Officer
- Source
- SEC Form 4
More RAPP insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.